($GEVA): Synageva BioPharma Corp. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. The stock has formed a loose base going back to November of last year. A move over 52.50 and we will look at the March 50 calls.
